KYVERNA THERAPEUTICS INC (KYTX) Stock Earnings & Estimates
USA - NASDAQ:KYTX - US5019761049 - Common Stock
6.63 USD
-0.38 (-5.42%)
6.63 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.656M | 7.025M 24.20% | -100.00% | 18.957M | 97.054M 411.97% | 225.04M 131.87% | 455.22M 102.28% | 717.92M 57.71% | 1.048B 45.98% | ||||
| EBITDA YoY % growth | -25.76M | -28.333M -9.99% | -63.196M -114.23% | -145.973M -132.07% | -195.039M -38.46% | -225.265M -15.50% | -289.586M -28.55% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -26.346M | -29.384M -11.53% | -63.082M -112.38% | -144.88M -129.14% | -188.948M -32.13% | -212.294M -12.36% | -263.309M -24.03% | -482.46M -83.23% | -534.48M -10.78% | -292.74M 45.23% | N/A | N/A | |
| Operating Margin | -465.81% | -418.28% | N/A | N/A | N/A | N/A | -1,388.98% | -497.10% | -237.50% | -64.31% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -8.79 | -3.36 60.53% | -3.88 -11.95% | -3.66 5.85% | -3.78 -3.30% | -4.08 -7.99% | -3.76 7.87% | -1.59 57.67% | 3.35 310.26% | 9.15 173.48% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.96 -20.06% | -0.91 -3.35% | -0.88 14.17% | -0.88 9.57% | -0.83 13.45% | -0.75 17.01% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||
| EBITDA Q2Q % growth | -44.88M -20.65% | -45.9M -17.97% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -43.74M -12.82% | -44.783M -9.12% | -40.29M 15.01% | -41.565M 6.41% | -43.35M 0.89% | -44.115M 1.49% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.97 -44.78% | -1.06 | 0.09 | 8.85% |
| Q1 2025 Q2Q % growth | -1.03 8.04% | -1.14 | 0.11 | 9.30% |
| Q4 2024 Q2Q % growth | -0.88 96.72% | -0.85 | -0.03 | -2.95% |
| Q3 2024 Q2Q % growth | -0.80 | -0.80 | 0.00 | 0.51% |
| Q2 2024 Q2Q % growth | -0.67 | -0.71 | 0.04 | 5.89% |
| Q1 2024 Q2Q % growth | -1.12 | -0.86 | -0.26 | -30.72% |
| Q4 2023 Q2Q % growth | -26.86 | -3.29 | -23.57 | -716.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.17% | -2.91% | 0% | -4.28% |
| Revenue | N/A | N/A | N/A | N/A |